The pursuit of new and effective drugs is a crucial pillar supporting better health. Highly collaborative and multidisciplinary research at UB navigates the complexities of drug discovery, development ...

Learn how integrin proteins are used as quality tools for targeted drug development.

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research ...

With pharmaceutical innovation representing one of the bright spots for positive change in health care, appreciating the impact of policy is key to a healthier and more competitive America.

Human infection challenge studies (HICs) are powerful in establishing early proof-of-concept for experimental drugs and understanding disease pathogenesis. A comprehensive assessment of HICs will ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can be addressed.

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how sponsors can align with FDA expectations and implement more precise ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before.

Many nations rely on the United States to shoulder the costs of not just global security, but also developing pharmaceuticals.